FDA inspection
QuVa Pharma, Inc.: FDA inspection ending Oct 28, 2024
FDA inspection 1238474 · Voluntary Action Indicated (VAI) · Sugar Land, TX
Key facts
| Inspection ID | 1238474 |
|---|---|
| Firm | QuVa Pharma, Inc. |
| FEI number | 3012053582 |
| Address | 1075 W Park One Dr Ste 100 |
| City | Sugar Land |
| State | TX |
| ZIP | 77478 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Oct 28, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data